NOREPINEPHRINE BITARTRATE and OFF LABEL USE

Overview

OFF LABEL USE is the #3 most commonly reported adverse reaction for NOREPINEPHRINE BITARTRATE, manufactured by Deseret Biologicals, Inc.. There are 1,270 FDA adverse event reports linking NOREPINEPHRINE BITARTRATE to OFF LABEL USE. This represents approximately 3.6% of all 35,563 adverse event reports for this drug.

Patients taking NOREPINEPHRINE BITARTRATE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE1,270 of 35,563 reports

OFF LABEL USE is moderately reported among NOREPINEPHRINE BITARTRATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of NOREPINEPHRINE BITARTRATE

In addition to off label use, the following adverse reactions have been reported for NOREPINEPHRINE BITARTRATE:

DRUG INEFFECTIVE — 2,740 reports
HYPOTENSION — 1,392 reports
ACUTE KIDNEY INJURY — 890 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME — 804 reports
SEPSIS — 790 reports
CONDITION AGGRAVATED — 777 reports
RENAL FAILURE — 728 reports
TOXICITY TO VARIOUS AGENTS — 708 reports
CARDIAC ARREST — 698 reports
CARDIOGENIC SHOCK — 664 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, IBUPROFEN

Does NOREPINEPHRINE BITARTRATE cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 1,270 FDA reports for NOREPINEPHRINE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with NOREPINEPHRINE BITARTRATE?

OFF LABEL USE accounts for approximately 3.6% of all adverse event reports for NOREPINEPHRINE BITARTRATE, making it one of the most commonly reported side effect.

What should I do if I experience OFF LABEL USE while taking NOREPINEPHRINE BITARTRATE?

If you experience off label use while taking NOREPINEPHRINE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.